Wow, what a bull trap that announcement turned out to be!!
Three things to look for in the Oasis trial, firstly will the Oncolytic virus attack the tumour through IV, then will it paint the CD19 onto the surface of the tumour and finally will it allow the CD19 attacking treatment to effect the tumour environment.
Any success in one of these will be a huge positive for this trial, we know it is already safe so that is a given.
Success in all three and the gloves will be off and every other pharma selling CD19 targeted treatment will be knocking down our door.
Remember we only need 1% of the market to be off to the races.
DYOR opinion only
Ann: Imugene onCARlytics Doses First Patient in IV Combination, page-45
-
- There are more pages in this discussion • 167 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.3¢ |
Change
-0.002(2.78%) |
Mkt cap ! $385.8M | |||
| Open | High | Low | Value | Volume |
| 5.3¢ | 5.4¢ | 5.2¢ | $355.8K | 6.732M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 44 | 2458262 | 5.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.3¢ | 1386147 | 18 |
View Market Depth
| Last trade - 15.09pm 15/08/2024 (20 minute delay) ? |
| IMU (ASX) Chart |